CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-03 | RYAN THOMAS F JR Director | Exercise or conversion | +1,000 | $26.12 | $26K | 2,464 |
| 2021-03-03 | RYAN THOMAS F JR Director | Sale | −1,000 | $205.00 | $205K | 1,464 |
| 2021-03-03 | RYAN THOMAS F JR Director | Exercise or conversion · Stock Option (Right to Buy) | +1,000 | 0 | ||
| 2021-02-24 | Snodgres Jon Chief Financial Officer | Grant or award | +2,410 | 35,908 | ||
| 2021-02-24 | Snodgres Jon Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +2,910 | 2,910 | ||
| 2021-02-24 | KURIYEL RALF Senior VP, R&D | Grant or award | +1,686 | 27,340 | ||
| 2021-02-24 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +2,035 | 2,035 | ||
| 2021-02-24 | Hunt Anthony Chief Executive Officer | Grant or award | +10,437 | 243,764 | ||
| 2021-02-24 | Hunt Anthony Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | −12,601 | 12,601 | ||
| 2021-01-25 | Snodgres Jon Chief Financial Officer | Exercise or conversion | +4,000 | $33.87 | $135K | 33,498 |
| 2021-01-25 | Snodgres Jon Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,000 | 6,887 | ||
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −656 | $188.69 | $124K | 32,799 |
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −1,333 | $190.09 | $253K | 31,466 |
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −202 | $190.50 | $38K | 31,264 |
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −918 | $192.74 | $177K | 30,346 |
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −218 | $193.88 | $42K | 30,128 |
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −571 | $195.16 | $111K | 29,557 |
| 2021-01-04 | Snodgres Jon Chief Financial Officer | Sale | −59 | $195.77 | $12K | 29,498 |
| 2020-12-16 | KURIYEL RALF Senior VP, R&D | Sale | −435 | $186.18 | $81K | 25,654 |
| 2020-11-19 | Hunt Anthony Chief Executive Officer | Exercise or conversion | +20,000 | $26.05 | $521K | 253,327 |
Page 31 of 42 · 832 trades